Academic Journal
Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy
| العنوان: | Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy |
|---|---|
| المؤلفون: | Bolkun, Lukasz, Pienkowski, Tomasz, Sieminska, Julia, Godzien, Joanna, Pietrowska, Karolina, Kłoczko, Janusz, Wierzbowska, Agnieszka, Moniuszko, Marcin, Ratajczak, Mariusz, Kretowski, Adam, Ciborowski, Michal |
| المساهمون: | Uniwersytet Medyczny w Białymstoku, Ministerstwo Edukacji i Nauki |
| المصدر: | Scientific Reports ; volume 13, issue 1 ; ISSN 2045-2322 |
| بيانات النشر: | Springer Science and Business Media LLC |
| سنة النشر: | 2023 |
| الوصف: | The heterogeneity of acute myeloid leukemia (AML), a complex hematological malignancy, is caused by mutations in myeloid cells affecting their differentiation and proliferation. Thus, various cytogenetic alterations in AML cells may be characterized by a unique metabolome and require different treatment approaches. In this study, we performed untargeted metabolomics to assess metabolomics differences between AML patients and healthy controls, AML patients with different treatment outcomes, AML patients in different risk groups based on the 2017 European LeukemiaNet (ELN) recommendations for the diagnosis and management of AML, AML patients with and without FLT3-ITD mutation, and a comparison between patients with FLT3-ITD, CBF-AML (Core binding factor acute myelogenous leukemia), and MLL AML (mixed-lineage leukemia gene) in comparison to control subjects. Analyses were performed in serum samples using liquid chromatography coupled with mass spectrometry (LC–MS). The obtained metabolomics profiles exhibited many alterations in glycerophospholipid and sphingolipid metabolism and allowed us to propose biomarkers based on each of the above assessments as an aid for diagnosis and eventual classification, allowing physicians to choose the best-suited treatment approach. These results highlight the application of LC–MS-based metabolomics of serum samples as an aid in diagnostics and a potential minimally invasive prognostic tool for identifying various cytogenetic and treatment outcomes of AML. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1038/s41598-023-48970-0 |
| الاتاحة: | http://dx.doi.org/10.1038/s41598-023-48970-0 https://www.nature.com/articles/s41598-023-48970-0.pdf https://www.nature.com/articles/s41598-023-48970-0 |
| Rights: | https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0 |
| رقم الانضمام: | edsbas.CE48244C |
| قاعدة البيانات: | BASE |
| DOI: | 10.1038/s41598-023-48970-0 |
|---|